About Prof. Jean Pierre
  • Summary Of Present Work

    His interest is directed towards therapeutic nanoparticle-based strategies that do not rely on the “Enhanced Permeability and Retention” effect. Among them, the design of various implants including intracerebral systems is currently achieved. In parallel, the targeting of a particular subset of immune cells, the monocytic myeloid-derived suppressor cells (M-MDSC), localized in the lymph nodes, is studied in order to propose new avenues in nano-immunotherapy. Two European projects from the EuroNanoMed program and coordinated by Prof. Benoit (NICHE and RESOLVE) are focusing on these aspects.